Watch short version here
The Stop TB’s Global Drug Facility (GDF) set up the Pediatric Drug-Resistant TB initiative aiming to ensure access to the best possible treatments to children suffering from one of the deadliest diseases that exist.
عربي
中文
Français
日本語
Русский
Español
No more injectables!
For decades, there were no child-friendly medicines to treat drug-resistant TB, so doctors had to treat them with drugs created for adults.
But that is changing, now there are new child-friendly medicines to treat drug-resistant TB in children.
See below the impact of Stop TB’s GDF in the lives of people affected by TB.
We support people affected by TB, whoever or wherever they may be
The global community has the capacity and means to end TB.
It’s Time
StopTB/GDF Pediatric DR-TB Initiative Results
GDF's Pediatric DR-TB Initiative has been dedicated to expedite the development, adoption, and scaleup of child-friendly medicines and treatment regimens for DR-TB. Funded by the Government of Japan and United States Agency for International Development (USAID), the Initiative concluded in early 2024, with GDF successfully achieving its objective of introducing child-friendly formulations for all 11 oral medicines the World Health Organization recommends for the treatment of DR-TB in children.
GDF’s Pediatric DR-TB Initiative - Key Achievements "2-pager" (English & Japanese)
Download
